The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Steady-state plasma levels of nortriptyline in twins: Influence of genetic factors and drug therapy
Open accessAbstract
Nineteen identical (monozygotic) and 20 fraternal (dizygotic) sets of twins between 45 and 51 years of age were given nortriptyline orally in doses of 0.2 mg./kg. body weight three times daily for eight days. The steady-state plasma concentrations of nortriptyline were calculated from the mean of the determinations for days 6, 7, and 8. Identical twins, not treated with other drugs, achieved similar steady-state plasma concentrations of nortriptyline in contrast to fraternal twins who were not given other drugs. The intrapair similarity in steady-state plasma concentrations was not found in identical twins simultaneously treated with various drugs during the experiment. Identical and fraternal twins treated with drugs containing barbiturates had considerably lower steady-state plasma concentrations of nortriptyline compared with untreated twins.It is concluded that most of the variability in nor-triptyline steady-state plasma concentration between persons who have not received drugs is genetically determined. Exposure to other drugs also influences the steady-state plasma concentration of nortriptyline, which in a given patient may therefore be determined by a resultant of genetic and environmental factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical pharmacology and therapeutics
Fenn, G. C. (1990) · Postgraduate Medical Journal · doi:10.1136/pgmj.66.778.686 · Cited by 479
Hammer, W., & Sjöqvist, F. (1967) · Life Sciences · doi:10.1016/0024-3205(67)90218-4 · Cited by 262
Genetic Control of Drug Levels in Man: Antipyrine
Vesell, E. S., & Page, J. G. (1968) · Science · doi:10.1126/science.161.3836.72 · Cited by 220
Genetic Control of Drug Levels in Man: Phenylbutazone
Vesell, E. S., & Page, J. G. (1968) · Science · doi:10.1126/science.159.3822.1479 · Cited by 177
Genetic control of dicumarol levels in man
Vesell, E. S., & Page, J. G. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105949 · Cited by 153
Enzyme Stimulation and Inhibition in the Metabolism of Drugs
Burns, J. J., & Conney, A. H. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505811p203 · Cited by 69
Pharmacokinetics of Accumulation
van Rossum, J. M. (1968) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600571230 · Cited by 52
Some pharmacological consequences of species variation in rates of metabolism.
Bb, B., & Reid, W. D. (1967) · PubMed · Cited by 30
Cited by
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part I
Zhou, S.-F. (2009) · Clinical Pharmacokinetics · doi:10.2165/11318030-000000000-00000 · Cited by 756
Ingelman-Sundberg, M. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.007 · Cited by 676
Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs
Bertilsson, L., Dahl, M., Dalén, P., & Al‐Shurbaji, A. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01548.x · Cited by 579
Kirchheiner, J., Brøsen, K., Dahl, M. L., Gram, L. F., Kasper, S., Roots, I., Sjöqvist, F., Spina, E., & Brockmöller, J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00299.x · Cited by 422
Metadata
- Authors
- Alexanderson, B., Price Evans, D. A., & Sjoqvist, F.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1969-12-27
- Volume
- 4
- Issue
- 5686
- Pages
- 764-768
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1968785130
- Cited by
- 359
- References
- 8
- FWCI
- 21.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.